ONCOSSENCE

PRECISELY TARGET AND ACTIVATE PATIENTS AND THEIR PROVIDERS TO INCREASE EARLY CANCER DIAGNOSES, OPTIMIZE TREATMENTS AND IMPROVE HEALTH OUTCOMES.

Close oncology care gaps. Enhance patient outcomes.

ONCOSSENCETM is a solution to identify, educate and activate target patients and their providers/clinical care teams to address critical oncology care needs. Drive cancer screenings, optimize treatment and support medication adherence across key cancer types. Leverage real-world data and the trusted voices of their healthcare provider to initiate meaningful health encounters between patients and their care teams.

Identify and engage patients (and their treating HCP) based on their medical history and approved guidelines to schedule an appointment for recommended cancer screening.
Identify and engage patients (and their treating oncologist)  currently on specific therapies for approved indications to provide education on side effect management and treatment expectations.
Identify and engage patients (and their treating oncologist) on current treatment protocols who may be candidates for additional adjuvant and/or concomitant therapies to schedule an appointment to discuss treatment options.
Personalized communications are delivered to patients and their PCP/oncologists in the voice of their trusted healthcare provider at critical points in their oncology care journey. Through omnichannel communications (email, SMS or direct mail messaging), ONCOSSENCE prompts meaningful health encounters between patients and their care teams to schedule a cancer screening, discuss treatment options or manage side effects.

Estimated addressable patient population eligible for cancer screenings across our network

50-74 YEARS OLD

0 M
ELIGIBLE FOR BREAST CANCER SCREENING

50-80 YEARS OLD

0 M
ELIGIBLE FOR LUNG CANCER SCREENING

16-23 YEARS OLD

0 M
ELIGIBLE FOR COLORECTAL CANCER

9-17 YEARS OLD

0 M
ELIGIBLE FOR CERVICAL CANCER SCREENING

60+ YEARS OLD

0 M
ELIGIBLE FOR PROSTATE CANCER SCREENING

Estimated addressable patient population eligible for cancer screenings across our network

50-74 YEARS OLD

0 M
ELIGIBLE FOR BREAST CANCER SCREENING

50-80 YEARS OLD

0 M
ELIGIBLE FOR LUNG CANCER SCREENING

16-23 YEARS OLD

0 M
ELIGIBLE FOR COLORECTAL CANCER SCREENING

9-17 YEARS OLD

0 M
ELIGIBLE FOR CERVICAL CANCER SCREENING

60+ YEARS OLD

0 M
ELIGIBLE FOR PROSTATE CANCER SCREENING

The Oncossence Patient Journey

1

Identification

Patients and their care teams are identified and divided into cohorts through claims, EHR or pharmacy data based on screening eligibility, current treatment protocols or potential care gaps.

2

Outreach

Personalized communications are sent to patients and their physicians/clinical care teams via SMS, email, direct mail or directly in the EHR in the trusted voice of their healthcare provider. These messages include educational content on the importance of screening, additional guidelines-based therapies or treatment expectations.

3

Engagement

Patients are encouraged to take action, such as scheduling a screening appointment or discussing treatment options with their oncologist. For those who have not responded, follow up messages are sent, ensuring multiple touchpoints.

4

Action

Activated patients visit their providers for screenings, treatment discussions or side effect management.

5

Follow up

For patients needing ongoing care or medication adherence support, follow-up reminders and educational materials are sent to ensure continuity of care.

6

Tracking

Patient actions and outcomes are captured via claims, EHR and pharmacy data, ensuring direct, comprehensive reporting on the program’s impact directly from the source.

Learn more
about Oncossence

Leverage the power of real-world data to identify, educate and activate patients and their care teams.